chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Peripheral swelling, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Red arm; big swollen arm; Vaccination site pain; vaccination site pruritus; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red arm), PERIPHERAL SWELLING (big swollen arm), FATIGUE (fatigue), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE PRURITUS (vaccination site pruritus) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unk and unk) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (fatigue). On an unknown date, the patient experienced ERYTHEMA (Red arm), PERIPHERAL SWELLING (big swollen arm), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE PRURITUS (vaccination site pruritus). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Red arm), PERIPHERAL SWELLING (big swollen arm), FATIGUE (fatigue), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE PRURITUS (vaccination site pruritus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included heart medicines and blood pressure pills.   This case was linked to MOD-2021-033898 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fall
Clinical narrative: dizzy; feeling weak; fell down on her bed after getting up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ASTHENIA (feeling weak) and FALL (fell down on her bed after getting up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) and ATORVASTATIN for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (dizzy), ASTHENIA (feeling weak) and FALL (fell down on her bed after getting up). At the time of the report, DIZZINESS (dizzy), ASTHENIA (feeling weak) and FALL (fell down on her bed after getting up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Nasal congestion, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: got COVID positive; soreness of arm; headache; stuffy nose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness of arm), HEADACHE (headache), NASAL CONGESTION (stuffy nose) and COVID-19 (got COVID positive) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), HCTZ, LEVOTHYROXINE SODIUM (SYNTHROID), ROSUVASTATIN CALCIUM (CRESTOR), ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and ZINC for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness of arm), HEADACHE (headache) and NASAL CONGESTION (stuffy nose). On 28-Jan-2021, the patient experienced COVID-19 (got COVID positive). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, 2 tablets and PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (THERAFLU DAYTIME) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness of arm), HEADACHE (headache), NASAL CONGESTION (stuffy nose) and COVID-19 (got COVID positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, SARS-CoV-2 test: Positive and Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: Over time Rash is spreading to the right side of the body and on left arm there is random stabbing pain as well.; Over time Rash is spreading to the right side of the body and on left arm there is random stabbing pain as well.; Patient noticed rash(small red or brown dots) on same evening on his lower left arm (bicep area) after receiving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Patient noticed rash(small red or brown dots) on same evening on his lower left arm (bicep area) after receiving 2nd dose), RASH (Over time Rash is spreading to the right side of the body and on left arm there is random stabbing pain as well.) and PAIN (Over time Rash is spreading to the right side of the body and on left arm there is random stabbing pain as well.) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011520A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION HYDROCHLORIDE (WELLBUTRIN), OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), TESTOSTERONE and Orthovisc Injection every for an unknown indication.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 27-Jan-2021, the patient experienced RASH (Patient noticed rash(small red or brown dots) on same evening on his lower left arm (bicep area) after receiving 2nd dose). On 03-Mar-2021, the patient experienced RASH (Over time Rash is spreading to the right side of the body and on left arm there is random stabbing pain as well.) and PAIN (Over time Rash is spreading to the right side of the body and on left arm there is random stabbing pain as well.). At the time of the report, RASH (Patient noticed rash(small red or brown dots) on same evening on his lower left arm (bicep area) after receiving 2nd dose), RASH (Over time Rash is spreading to the right side of the body and on left arm there is random stabbing pain as well.) and PAIN (Over time Rash is spreading to the right side of the body and on left arm there is random stabbing pain as well.) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment medications were not reported.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Got dizzy; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Got dizzy) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced DIZZINESS (Got dizzy) and HEADACHE (Headache). At the time of the report, DIZZINESS (Got dizzy) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.    This case was linked to MOD-2021-033901 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Platelet count decreased
Clinical narrative: Rash due to platelet depletion.; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT DECREASED (Rash due to platelet depletion.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PLATELET COUNT DECREASED (Rash due to platelet depletion.). At the time of the report, PLATELET COUNT DECREASED (Rash due to platelet depletion.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Musculoskeletal stiffness, Rhinorrhoea, Vaccination site erythema
Clinical narrative: runny nose; right hand felt tight; 3 inch welt; redness; itchy; joints hurt; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), VACCINATION SITE URTICARIA (3 inch welt), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PRURITUS (itchy) and MUSCULOSKELETAL STIFFNESS (right hand felt tight) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (runny nose), VACCINATION SITE URTICARIA (3 inch welt), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PRURITUS (itchy), MUSCULOSKELETAL STIFFNESS (right hand felt tight), ARTHRALGIA (joints hurt) and FATIGUE (felt tired). At the time of the report, RHINORRHOEA (runny nose), VACCINATION SITE URTICARIA (3 inch welt), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PRURITUS (itchy), MUSCULOSKELETAL STIFFNESS (right hand felt tight), ARTHRALGIA (joints hurt) and FATIGUE (felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), URTICARIA (3 inch welt), ERYTHEMA (redness), PRURITUS (itchy) and MUSCULOSKELETAL STIFFNESS (right hand felt tight) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rhinorrhoea, Urticaria, Erythema, Pruritus, Arthralgia, Fatigue and Musculoskeletal stiffness.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced RHINORRHOEA (runny nose), URTICARIA (3 inch welt), ERYTHEMA (redness), PRURITUS (itchy), MUSCULOSKELETAL STIFFNESS (right hand felt tight), ARTHRALGIA (joints hurt) and FATIGUE (felt tired). At the time of the report, RHINORRHOEA (runny nose), URTICARIA (3 inch welt), ERYTHEMA (redness), PRURITUS (itchy), MUSCULOSKELETAL STIFFNESS (right hand felt tight), ARTHRALGIA (joints hurt) and FATIGUE (felt tired) outcome was unknown.            Reporter did not allow further contact   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: runny nose; right hand felt tight; 3 inch welt; redness; itchy; joints hurt; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), VACCINATION SITE URTICARIA (3 inch welt), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PRURITUS (itchy) and MUSCULOSKELETAL STIFFNESS (right hand felt tight) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (runny nose), VACCINATION SITE URTICARIA (3 inch welt), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PRURITUS (itchy), MUSCULOSKELETAL STIFFNESS (right hand felt tight), ARTHRALGIA (joints hurt) and FATIGUE (felt tired). At the time of the report, RHINORRHOEA (runny nose), VACCINATION SITE URTICARIA (3 inch welt), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PRURITUS (itchy), MUSCULOSKELETAL STIFFNESS (right hand felt tight), ARTHRALGIA (joints hurt) and FATIGUE (felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), URTICARIA (3 inch welt), ERYTHEMA (redness), PRURITUS (itchy) and MUSCULOSKELETAL STIFFNESS (right hand felt tight) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rhinorrhoea, Urticaria, Erythema, Pruritus, Arthralgia, Fatigue and Musculoskeletal stiffness.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced RHINORRHOEA (runny nose), URTICARIA (3 inch welt), ERYTHEMA (redness), PRURITUS (itchy), MUSCULOSKELETAL STIFFNESS (right hand felt tight), ARTHRALGIA (joints hurt) and FATIGUE (felt tired). At the time of the report, RHINORRHOEA (runny nose), URTICARIA (3 inch welt), ERYTHEMA (redness), PRURITUS (itchy), MUSCULOSKELETAL STIFFNESS (right hand felt tight), ARTHRALGIA (joints hurt) and FATIGUE (felt tired) outcome was unknown.            Reporter did not allow further contact   Reporter did not allow further contact
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Headaches; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) and PAIN IN EXTREMITY (Sore arm) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 014M20A) for COVID-19 vaccination.     The patient's past medical history included Gastrointestinal disorder since an unknown date. Concomitant products included LINACLOTIDE (LINZESS) and SUCRALFATE (CARAFATE) for Gastrointestinal disorder, MULTIVITAMINS;MINERALS for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headaches) and PAIN IN EXTREMITY (Sore arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL (TYLENOL EXTRA S. P) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (Headaches) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.    This case was linked to MOD-2021-227487 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Energy increased, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (usual soreness) and ENERGY INCREASED (high levels of energy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ENERGY INCREASED (high levels of energy). On an unknown date, the patient experienced PAIN (usual soreness). At the time of the report, PAIN (usual soreness) and ENERGY INCREASED (high levels of energy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Injection site pain
Clinical narrative: fatigue; sore arm; shoulder pain in injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), INJECTION SITE PAIN (sore arm) and ARTHRALGIA (shoulder pain in injection site arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20a) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced FATIGUE (fatigue), INJECTION SITE PAIN (sore arm) and ARTHRALGIA (shoulder pain in injection site arm). At the time of the report, FATIGUE (fatigue), INJECTION SITE PAIN (sore arm) and ARTHRALGIA (shoulder pain in injection site arm) outcome was unknown. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided by Reporter.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Tenderness at injection site, nothing serious; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Tenderness at injection site, nothing serious) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Tenderness at injection site, nothing serious). At the time of the report, VACCINATION SITE PAIN (Tenderness at injection site, nothing serious) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Erythema, Fatigue
Clinical narrative: Chills; Achy joints; Arm puffed up; Redness on the left shoulder; Nauseous; Gassy; Tired; Weak; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), ARTHRALGIA (Achy joints), PERIPHERAL SWELLING (Arm puffed up), ERYTHEMA (Redness on the left shoulder) and NAUSEA (Nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (Chills), ARTHRALGIA (Achy joints), PERIPHERAL SWELLING (Arm puffed up), ERYTHEMA (Redness on the left shoulder), NAUSEA (Nauseous), FLATULENCE (Gassy), FATIGUE (Tired) and ASTHENIA (Weak). At the time of the report, CHILLS (Chills), ARTHRALGIA (Achy joints), PERIPHERAL SWELLING (Arm puffed up), ERYTHEMA (Redness on the left shoulder), NAUSEA (Nauseous) and FLATULENCE (Gassy) outcome was unknown and FATIGUE (Tired) and ASTHENIA (Weak) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Flatulence, Nausea, Peripheral swelling
Clinical narrative: Chills; Achy joints; Arm puffed up; Redness on the left shoulder; Nauseous; Gassy; Tired; Weak; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), ARTHRALGIA (Achy joints), PERIPHERAL SWELLING (Arm puffed up), ERYTHEMA (Redness on the left shoulder) and NAUSEA (Nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (Chills), ARTHRALGIA (Achy joints), PERIPHERAL SWELLING (Arm puffed up), ERYTHEMA (Redness on the left shoulder), NAUSEA (Nauseous), FLATULENCE (Gassy), FATIGUE (Tired) and ASTHENIA (Weak). At the time of the report, CHILLS (Chills), ARTHRALGIA (Achy joints), PERIPHERAL SWELLING (Arm puffed up), ERYTHEMA (Redness on the left shoulder), NAUSEA (Nauseous) and FLATULENCE (Gassy) outcome was unknown and FATIGUE (Tired) and ASTHENIA (Weak) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Severe dizziness/cannot really lift my head or get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Severe dizziness/cannot really lift my head or get out of bed) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 immunisation.     Concurrent medical conditions included Hypertension and Cholesterol. Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced DIZZINESS (Severe dizziness/cannot really lift my head or get out of bed). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DIZZINESS (Severe dizziness/cannot really lift my head or get out of bed) outcome was unknown.            Concomitant medication included blood pressure medication, cholesterol medication and vitamins in the morning.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Illness, Intentional product use issue, Myalgia
Clinical narrative: Sick; I did not want to take the second shot. Am I still eligible to receive the 2nd shot?; Extreme fatigue; Muscle pain; Body ache; Heart palpitations; It felt like the vaccine would kill her; Vomiting; Nausea; Fever (101)/ fever of 102.5 for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (I did not want to take the second shot. Am I still eligible to receive the 2nd shot?), MYALGIA (Body ache), ILLNESS (Sick), PALPITATIONS (Heart palpitations) and VACCINATION COMPLICATION (It felt like the vaccine would kill her) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced MYALGIA (Body ache) and PYREXIA (Fever (101)/ fever of 102.5 for 3 days). 14-Jan-2021, the patient experienced PALPITATIONS (Heart palpitations), VACCINATION COMPLICATION (It felt like the vaccine would kill her), VOMITING (Vomiting), NAUSEA (Nausea) and MYALGIA (Muscle pain). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (I did not want to take the second shot. Am I still eligible to receive the 2nd shot?), ILLNESS (Sick) and FATIGUE (Extreme fatigue). On 16-Jan-2021, PYREXIA (Fever (101)/ fever of 102.5 for 3 days) had resolved. At the time of the report, INTENTIONAL PRODUCT USE ISSUE (I did not want to take the second shot. Am I still eligible to receive the 2nd shot?) had resolved and MYALGIA (Body ache), ILLNESS (Sick), PALPITATIONS (Heart palpitations), VACCINATION COMPLICATION (It felt like the vaccine would kill her), VOMITING (Vomiting), NAUSEA (Nausea), FATIGUE (Extreme fatigue) and MYALGIA (Muscle pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Body temperature: 101 (High) 101 and 102.5 (High) 102.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow- up included additional events (fatigue, muscle pain, nausea, vomiting, heart palpitations and vaccination adverse reaction)
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Palpitations, Pyrexia, Vaccination complication, Vomiting
Clinical narrative: Sick; I did not want to take the second shot. Am I still eligible to receive the 2nd shot?; Extreme fatigue; Muscle pain; Body ache; Heart palpitations; It felt like the vaccine would kill her; Vomiting; Nausea; Fever (101)/ fever of 102.5 for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (I did not want to take the second shot. Am I still eligible to receive the 2nd shot?), MYALGIA (Body ache), ILLNESS (Sick), PALPITATIONS (Heart palpitations) and VACCINATION COMPLICATION (It felt like the vaccine would kill her) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced MYALGIA (Body ache) and PYREXIA (Fever (101)/ fever of 102.5 for 3 days). 14-Jan-2021, the patient experienced PALPITATIONS (Heart palpitations), VACCINATION COMPLICATION (It felt like the vaccine would kill her), VOMITING (Vomiting), NAUSEA (Nausea) and MYALGIA (Muscle pain). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (I did not want to take the second shot. Am I still eligible to receive the 2nd shot?), ILLNESS (Sick) and FATIGUE (Extreme fatigue). On 16-Jan-2021, PYREXIA (Fever (101)/ fever of 102.5 for 3 days) had resolved. At the time of the report, INTENTIONAL PRODUCT USE ISSUE (I did not want to take the second shot. Am I still eligible to receive the 2nd shot?) had resolved and MYALGIA (Body ache), ILLNESS (Sick), PALPITATIONS (Heart palpitations), VACCINATION COMPLICATION (It felt like the vaccine would kill her), VOMITING (Vomiting), NAUSEA (Nausea), FATIGUE (Extreme fatigue) and MYALGIA (Muscle pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Body temperature: 101 (High) 101 and 102.5 (High) 102.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow- up included additional events (fatigue, muscle pain, nausea, vomiting, heart palpitations and vaccination adverse reaction)
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pyrexia
Clinical narrative: fever; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) and PYREXIA (fever) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 17-Jun-2020 and the estimated date of delivery was 23-Mar-2021. On 30-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 27-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (fever). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 30-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. On 28-Feb-2021, PYREXIA (fever) had resolved.            No concomitant medication details was reported.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-033824 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Exposure during pregnancy, Underdose
Clinical narrative: When vaccination was administered, liquid leaked out of the needle resulting in a full dose not being administered; Administered liquid leaked out of the needle; Vaccine administered to pregnant patient; A spontaneous report was received from a pharmacist concerning a 32-year old pregnant female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced vaccine underdose, device connection issue and vaccine exposure during pregnancy.   The patient's medical history was not provided. No concomitant product use was reported.  On 02-Mar-2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 013M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. When vaccination was administered, liquid leaked out of the needle resulting in a full dose not being administered. It was unsure if less than half of the dose was administered.  No treatment for the events was reported.  Action taken with mRNA-1273 with respect to the events was not reported.  The outcomes of the events, vaccine underdose, device connection issue and vaccine exposure during pregnancy, were considered recovered/resolved.; Reporter's Comments: This report refers to a case of vaccine underdose, syringe connection issue and exposure during pregnancy for mRNA-1273, lot #013M20A with no associated AEs.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain in extremity
Clinical narrative: soreness in the arm,very sore; couldn't sleep well; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm,very sore) and INSOMNIA (couldn't sleep well) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in the arm,very sore) and INSOMNIA (couldn't sleep well). At the time of the report, PAIN IN EXTREMITY (soreness in the arm,very sore) and INSOMNIA (couldn't sleep well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Info was received consumer wants the form to be mail to her address no  new information was added
Sex: F
Vaccine: COVID19
Symptoms: Lacrimation increased, Sinusitis
Clinical narrative: eyes were running; Sinuses were super bad; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (eyes were running) and SINUSITIS (Sinuses were super bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced LACRIMATION INCREASED (eyes were running) and SINUSITIS (Sinuses were super bad). At the time of the report, LACRIMATION INCREASED (eyes were running) and SINUSITIS (Sinuses were super bad) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Pyrexia
Clinical narrative: high fever; palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever) and PALPITATIONS (palpitations) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Anemia (Mild anemia) and Kidney disorder.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (high fever) and PALPITATIONS (palpitations). At the time of the report, PYREXIA (high fever) and PALPITATIONS (palpitations) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: patient details added, action taken updated, medical history added
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headaches daily; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches daily) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20a) for COVID-19 vaccination.    Co-suspect product included non-company product Parkinson's for an unknown indication.    Concurrent medical conditions included Parkinson's disease.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started Parkinson's (unknown route) at an unspecified dose. On 27-Jan-2021, the patient experienced HEADACHE (Headaches daily). At the time of the report, HEADACHE (Headaches daily) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: NNI  attached.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: diarrhea; muscle pain; joint pain; chills; nausea and vomiting; nausea and vomiting; fever; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills) and NAUSEA (nausea and vomiting) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (diarrhea), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea and vomiting), VOMITING (nausea and vomiting), PYREXIA (fever), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, DIARRHOEA (diarrhea), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea and vomiting), VOMITING (nausea and vomiting), PYREXIA (fever), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: diarrhea; muscle pain; joint pain; chills; nausea and vomiting; nausea and vomiting; fever; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills) and NAUSEA (nausea and vomiting) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (diarrhea), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea and vomiting), VOMITING (nausea and vomiting), PYREXIA (fever), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, DIARRHOEA (diarrhea), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea and vomiting), VOMITING (nausea and vomiting), PYREXIA (fever), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02959200) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-Jul-2020 and the estimated date of delivery was 17-Jun-2021. On 03-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fifth week of the pregnancy.  On 03-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Sep-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had two pregnancies which were live and full term birth.   Concomitant product was not provided.  The patient did not have any complications or acute illnesses during this pregnancy till date.  Treatment medication was not reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unkown) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-031469 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-031469:Patient Wife case
Age: 119.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Diarrhoea, Pain, Pain in extremity
Clinical narrative: Diarrhea; Leg hurts; Back hurts; Aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Leg hurts), BACK PAIN (Back hurts), PAIN (Aches) and CHILLS (Chills) in an 119-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Leg hurts), BACK PAIN (Back hurts), PAIN (Aches) and CHILLS (Chills). At the time of the report, DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Leg hurts), BACK PAIN (Back hurts), PAIN (Aches) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Followup received on 21-JUL-2021, Fax Number Updated
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Fatigue, Heart rate increased, Nausea, Pain
Clinical narrative: Fast heartbeat; lower Abdominal pain; Fatigue; soreness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast heartbeat), ABDOMINAL PAIN LOWER (lower Abdominal pain), FATIGUE (Fatigue), PAIN (soreness) and NAUSEA (Nausea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HEART RATE INCREASED (Fast heartbeat), ABDOMINAL PAIN LOWER (lower Abdominal pain), FATIGUE (Fatigue), PAIN (soreness) and NAUSEA (Nausea). At the time of the report, HEART RATE INCREASED (Fast heartbeat), ABDOMINAL PAIN LOWER (lower Abdominal pain), FATIGUE (Fatigue), PAIN (soreness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling, Vaccination site induration, Vaccination site warmth
Clinical narrative: swelling; hard to the touch; large red spot; hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of RASH (large red spot), VACCINATION SITE WARMTH (hot to the touch), SWELLING (swelling) and VACCINATION SITE INDURATION (hard to the touch) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced RASH (large red spot) and VACCINATION SITE WARMTH (hot to the touch). On an unknown date, the patient experienced SWELLING (swelling) and VACCINATION SITE INDURATION (hard to the touch). At the time of the report, RASH (large red spot), VACCINATION SITE WARMTH (hot to the touch), SWELLING (swelling) and VACCINATION SITE INDURATION (hard to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, SARS-CoV-1 test
Clinical narrative: Flu like symptoms for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms for 3 days) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A2(orZ)1A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 06-Jan-2021.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms for 3 days). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms for 3 days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, SARS-CoV-1 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: within 10 days I developed Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (within 10 days I developed Covid) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ZINC, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), CALCIUM, ATORVASTATIN, EZETIMIBE (ZETIA), TIZANIDINE HYDROCHLORIDE (ZANAFLEX), FISH OIL, ESCITALOPRAM and LEVOTHYROXINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (within 10 days I developed Covid). The patient was treated with IBUPROFEN at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 1 dosage form. At the time of the report, COVID-19 (within 10 days I developed Covid) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.